Gangwon, South Korea

Kyeong-Cheon Jung

This inventor holds 6 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Dinona Inc.. Active years: 2009-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyeong-Cheon Jung. Retrieved from https://idiyas.com/inventor/kyeong-cheon-jung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 33.3

 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 13(Granted Patents)


Location History:

  • Seoul, KR (2011 - 2015)
  • Gangwon-do, KR (2009 - 2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kyeong-Cheon Jung: Innovator in Cancer Research

Introduction

Kyeong-Cheon Jung is a notable inventor based in Gangwon-do, South Korea. He has made significant contributions to the field of cancer research, particularly in the development of diagnostic and therapeutic applications for acute leukemia and lymphoblastic lymphoma. With a total of 6 patents to his name, Jung's work is paving the way for advancements in medical treatments.

Latest Patents

One of his latest patents is titled "Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof." This invention focuses on a CD43 epitope expressed on human acute leukemia and lymphoblastic lymphoma cells, which is not present on mature hematopoietic cells, hematopoietic stem cells, or non-hematopoietic cells. The patent outlines its diagnostic and therapeutic applications for these types of cancer.

Another significant patent is "Antibody modulating the differentiation and function of dendritic cells via binding intercellular adhesion molecule-1 and use thereof." This invention describes an antibody that binds to human intercellular adhesion molecule-1 (ICAM-1), which can modulate the differentiation status of dendritic cells and prolong graft survival. The patent also includes a pharmaceutical composition comprising the antibody and methods for its use in treating diseases.

Career Highlights

Kyeong-Cheon Jung is currently associated with Dinona Inc., where he continues to innovate in the field of cancer research. His work has garnered attention for its potential impact on treatment methodologies and patient outcomes.

Collaborations

Jung collaborates with several talented individuals in his field, including Seong-Hoe Park and Seong-Pyo Park. Their combined expertise contributes to the advancement of research and development in cancer therapies.

Conclusion

Kyeong-Cheon Jung's contributions to cancer research through his patents and collaborations highlight his commitment to improving medical treatments. His innovative work continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…